IndraLab

Statements

Ginsenoside Rb1 inhibits IKBKB. 1 / 1

| 1

reach

"Ginsenoside Rb1 and its metabolite compound inhibited the activation of key inflammatory mediators IRAK-1 (interleukin-1 receptor associated kinase-1), IKK-beta (inhibitor of NF-kappabeta kinase), NF-kappabeta, and MAPK (mitogen activated protein kinases) while suppressing colitis [XREF_BIBR]."

22899889

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Ginsenoside Rb1 inhibits IKBKB. 1 / 1

INDRA sources:

Databases

Reading